(Q57396324)

English

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial

article by John McMurray et al published May 2006 in American Heart Journal

Statements

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
James B. Young
0 references
Steven Earle
0 references
Bertil Olofsson
0 references
Jan Östergren
0 references
May 2006
0 references
151
0 references
985-991
0 references
5
0 references

Identifiers

0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit